Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma
Tags
Data and Resources
To access the resources you must log in
This item has no data
Item URL
http://data.d4science.org/ctlg/RISIS2OpenData/dedup_wf_001--536f00c4488fc27d47c8a8eac393258e |
|
Identity
Access Modality
Field | Value |
---|---|
Access Right | Open Access |
Attribution
Field | Value |
---|---|
Author | Randeep Sangha |
Author | Davies, Andrew |
Author | Dang, Nam H. |
Author | Michinori Ogura |
Author | MacDonald, David A. |
Author | Revathi Ananthakrishnan |
Author | M. Luisa Paccagnella |
Author | Vandendries, Erik |
Author | Boni, Joseph |
Author | Yeow Tee Goh |
Publishing
Field | Value |
---|---|
Collected From | Datacite; figshare |
Hosted By | figshare |
Publication Date | 2017-04-04 |
Publisher | Taylor & Francis |
Additional Info
Field | Value |
---|---|
Language | UNKNOWN |
Resource Type | Dataset |
keyword | FOS: Chemical sciences |
keyword | CD22+ |
keyword | FOS: Biological sciences |
keyword | FOS: Clinical medicine |
system:type | dataset |
Management Info
Field | Value |
---|---|
Source | https://science-innovation-policy.openaire.eu/search/dataset?datasetId=dedup_wf_001::536f00c4488fc27d47c8a8eac393258e |
Author | jsonws_user |
Version | None |
Last Updated | 16 December 2020, 00:12 (CET) |
Created | 16 December 2020, 00:12 (CET) |